Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Carmat    ALCAR   FR0010907956

CARMAT (ALCAR)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/22 11:35:02 am
23 EUR   --.--%
2018CARMAT SA : half-yearly earnings release
2017CARMAT SA : half-yearly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
01/16/2019 01/17/2019 01/18/2019 01/21/2019 01/22/2019 Date
25.25(c) 24.65(c) 23.8(c) 23(c) 23 Last
8 553 12 500 14 477 14 745 4 311 Volume
-0.20% -2.38% -3.45% -3.36% 0.00% Change
More quotes
Financials (EUR)
Sales 2018 0,24 M
EBIT 2018 -36,6 M
Net income 2018 -38,3 M
Finance 2018 20,8 M
Yield 2018 -
Sales 2019 -
EBIT 2019 -33,7 M
Net income 2019 -33,8 M
Debt 2019 2,14 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 847x
EV / Sales2019 0
Capitalization 221 M
More Financials
Company
Carmat specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency who are ineligible for a transplant and have exhausted all... 
More about the company
Surperformance© ratings of Carmat
Trading Rating : Investor Rating :
More Ratings
Latest news on CARMAT
01/21CARMAT : 2019 Financial Calendar
BU
01/16CARMAT : presents positive interim results of the first part of its PIVOTAL stud..
AQ
01/15CARMAT : presents positive interim results of the first part of its PIVOTAL stud..
BU
2018CARMAT : Juncker Plan - The EIB supports CARMAT with EUR 30m
AQ
2018CARMAT : The European Investment Bank supports CARMAT with €30m for the marketin..
PU
2018CARMAT : The European Investment Bank Supports CARMAT with €30 Million for the M..
BU
2018CARMAT : Announces the Appointment of Pascale d'arbonneau as Chief Financial Off..
BU
2018CARMAT : Announces the Appointment of Jean-Pierre Garnier as Chairman of the Boa..
BU
2018CARMAT : reports its 2018 half-year results and provides an update on its develo..
BU
2018CARMAT : Half-year results
CO
More news
Analyst Recommendations on CARMAT
More recommendations
Sector news : Medical Devices & Implants
01/17BECTON DICKINSON AND : Says First-Quarter Profit Will Top Views
DJ
01/16PG&E to get pulled out of S&P 500, shares near 2001 lows
RE
01/16ABBOTT LABORATORIES : Exercises Option to Buy Cephea Valve Technologies
DJ
01/14ABBOTT LABORATORIES : Labs Gets FDA Approval for Amplatzer Piccolo Occluder
DJ
01/10Hearing aid makers Widex and Sivantos reopen EU merger application
RE
More sector news : Medical Devices & Implants
Chart CARMAT
Duration : Period :
Carmat Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARMAT
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 29,5 €
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Stéphane Piat Chief Executive Officer & Director
Jean-Pierre Garnier Chairman
Pascale d’Arbonneau Chief Financial & Administrative Officer
Marc Grimmé Director-Research & Development
Piet Jansen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
CARMAT-2.13%250
STRYKER CORPORATION6.89%62 695
SMITH & NEPHEW0.48%16 545
WRIGHT MEDICAL GROUP NV6.03%3 610
GLAUKOS CORP11.59%2 258
DOUBLE MEDICAL TECHNOLOGY INC--.--%1 742